Ernest Talarico III

Ernest Talarico III is a declared insider of Lumos Pharma, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 16 November 2011 to 10 July 2018, the count stands at 24 filings.

In open-market terms, that means 1 purchase worth €44k on one side and 4 sales worth €1.8M on the other. On balance, insiders were net sellers of €1.7M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants and 10 option exercises. So far in 2018, the count stands at no purchases and 1 sale.

The newest entry dates from 12 July 2018: an option exercise of €13k, in Lumos Pharma, Inc. The clock since the last published purchase (8 June 2016) now reads 3,806 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.